The C 536T Transition in the Tissue Factor Pathway Inhibitor Gene Is not a Common Cause of Venous Thromboembolic Disease in the UK Population

• References

• 1 Broze GJ. Tissue factor pathway inhibitor gene disruption. Blood Coagulation and Fibrinolysis 1998; 09: 89-92.
• 2 Miyata T, Sakata T, Kumeda K, Uchida K, Tsushima M, Fujimuru H, Kawasaki T, Kato H. C399-T Polymorphism in the promoter region of the Human Tissue Factor Pathway Inhibitor gene does not change the plasma TFPI antigen level and does not cause venous thrombosis. Thromb Haemost 1998; 80: 345-6.
• 3 Arnaud E, Moatti D, Emmerich J, Aiach M, de Prost D. No link between the TFPI V264M mutation and venous thromboembolic disease. Thromb Haemost 1999; 82: 159-60.
• 4 Kleesiek K, Schmidt M, Gotting C, Brinkman T, Prohaska W. A first mutation in the Human Tissue Factor Pathway Inhibitor gene encoding [P151L]TFPI. Blood 1998; 92: 3976-80.
• 5 Kleesiek K, Schmidt M, Gotting C, Schwenz B, Lange S, Muller-Berghaus G, Brinkman T, Prohaska W. The 536C-T transition in the Human Tissue Factor Pathway Inhibitor gene is statistically associated with a higher risk of venous thrombosis. Thromb Haemost 1999; 82: 1-5.